Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Efforts to remove aqueous lithium ion using Octolig® and methylated derivatives.

Martin DF, Bisht KS.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2018 Aug 24;53(10):946-949. doi: 10.1080/10934529.2018.1470969. Epub 2018 May 18.

PMID:
29775126
2.

Photopolymerization-based synthesis of iron oxide nanoparticle embedded PNIPAM nanogels for biomedical applications.

Denmark DJ, Hyde RH, Gladney C, Phan MH, Bisht KS, Srikanth H, Mukherjee P, Witanachchi S.

Drug Deliv. 2017 Nov;24(1):1317-1324. doi: 10.1080/10717544.2017.1373164.

PMID:
28906151
3.

Spatially Directional Resorcin[4]arene Cavitand Glycoconjugates for Organic Catalysis.

Husain AA, Maknenko AM, Bisht KS.

Chemistry. 2016 Apr 25;22(18):6223-7. doi: 10.1002/chem.201600352. Epub 2016 Mar 21.

PMID:
26933945
4.

In vitro inhibition activity of essential oils from some Lamiaceae species against phytopathogenic fungi.

Kumar V, Mathela CS, Tewari AK, Bisht KS.

Pestic Biochem Physiol. 2014 Sep;114:67-71. doi: 10.1016/j.pestbp.2014.07.001. Epub 2014 Jul 11.

PMID:
25175652
5.

The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.

Baskin R, Park SO, Keserű GM, Bisht KS, Wamsley HL, Sayeski PP.

PLoS One. 2014 Aug 27;9(8):e105568. doi: 10.1371/journal.pone.0105568. eCollection 2014.

6.

Protein kinase C δ (PKCδ) splice variants modulate apoptosis pathway in 3T3L1 cells during adipogenesis: identification of PKCδII inhibitor.

Patel R, Apostolatos A, Carter G, Ajmo J, Gali M, Cooper DR, You M, Bisht KS, Patel NA.

J Biol Chem. 2013 Sep 13;288(37):26834-46. doi: 10.1074/jbc.M113.482638. Epub 2013 Jul 31.

7.

The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis.

Kirabo A, Park SO, Wamsley HL, Gali M, Baskin R, Reinhard MK, Zhao ZJ, Bisht KS, Keserű GM, Cogle CR, Sayeski PP.

Am J Pathol. 2012 Sep;181(3):858-65. doi: 10.1016/j.ajpath.2012.05.033. Epub 2012 Jul 13.

8.

Identification of novel SAR properties of the Jak2 small molecule inhibitor G6: significance of the para-hydroxyl orientation.

Baskin R, Gali M, Park SO, Zhao ZJ, Keseru GM, Bisht KS, Sayeski PP.

Bioorg Med Chem Lett. 2012 Feb 1;22(3):1402-7. doi: 10.1016/j.bmcl.2011.12.042. Epub 2011 Dec 21.

9.

The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow.

Kirabo A, Park SO, Majumder A, Gali M, Reinhard MK, Wamsley HL, Zhao ZJ, Cogle CR, Bisht KS, Keserü GM, Sayeski PP.

Neoplasia. 2011 Nov;13(11):1058-68.

10.

A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth.

Majumder A, Magis AT, Park SO, Figueroa NC, Baskin R, Kirabo A, Allan RW, Zhao ZJ, Bisht KS, Keseru GM, Sayeski PP.

Exp Hematol. 2012 Jan;40(1):22-34. doi: 10.1016/j.exphem.2011.10.003. Epub 2011 Oct 20.

11.

The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo.

Kirabo A, Embury J, Kiss R, Polgár T, Gali M, Majumder A, Bisht KS, Cogle CR, Keseru GM, Sayeski PP.

J Biol Chem. 2011 Feb 11;286(6):4280-91. doi: 10.1074/jbc.M110.200774. Epub 2010 Dec 2.

12.

Structure-function correlation of G6, a novel small molecule inhibitor of Jak2: indispensability of the stilbenoid core.

Majumder A, Govindasamy L, Magis A, Kiss R, Polgár T, Baskin R, Allan RW, Agbandje-McKenna M, Reuther GW, Keseru GM, Bisht KS, Sayeski PP.

J Biol Chem. 2010 Oct 8;285(41):31399-407. doi: 10.1074/jbc.M110.168211. Epub 2010 Jul 28.

13.

SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress.

Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D.

Cancer Cell. 2010 Jan 19;17(1):41-52. doi: 10.1016/j.ccr.2009.11.023.

14.

Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening.

Kiss R, Polgár T, Kirabo A, Sayyah J, Figueroa NC, List AF, Sokol L, Zuckerman KS, Gali M, Bisht KS, Sayeski PP, Keseru GM.

Bioorg Med Chem Lett. 2009 Jul 1;19(13):3598-601. doi: 10.1016/j.bmcl.2009.04.138. Epub 2009 May 5.

15.

Spatially directional multiarm poly(epsilon-caprolactone) based on resorcin[4]arene cavitand core.

Wu R, Al-Azemi TF, Bisht KS.

Chem Commun (Camb). 2009 Apr 14;(14):1822-4. doi: 10.1039/b818790h. Epub 2008 Dec 24.

PMID:
19319413
16.

SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression.

Jacobs KM, Pennington JD, Bisht KS, Aykin-Burns N, Kim HS, Mishra M, Sun L, Nguyen P, Ahn BH, Leclerc J, Deng CX, Spitz DR, Gius D.

Int J Biol Sci. 2008 Sep 5;4(5):291-9.

17.

Functionalized polycarbonate derived from tartaric acid: enzymatic ring-opening polymerization of a seven-membered cyclic carbonate.

Wu R, Al-Azemi TF, Bisht KS.

Biomacromolecules. 2008 Oct;9(10):2921-8. doi: 10.1021/bm800696q. Epub 2008 Sep 5.

PMID:
18771312
18.

BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression.

Nguyen P, Bar-Sela G, Sun L, Bisht KS, Cui H, Kohn E, Feinberg AP, Gius D.

Mol Cell Biol. 2008 Nov;28(21):6720-9. doi: 10.1128/MCB.00568-08. Epub 2008 Sep 2.

19.

CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.

Nguyen P, Cui H, Bisht KS, Sun L, Patel K, Lee RS, Kugoh H, Oshimura M, Feinberg AP, Gius D.

Cancer Res. 2008 Jul 15;68(14):5546-51. doi: 10.1158/0008-5472.CAN-08-1005.

20.

DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.

Sun L, Huang L, Nguyen P, Bisht KS, Bar-Sela G, Ho AS, Bradbury CM, Yu W, Cui H, Lee S, Trepel JB, Feinberg AP, Gius D.

Cancer Res. 2008 Apr 15;68(8):2726-35. doi: 10.1158/0008-5472.CAN-07-6654.

21.

Synthesis of resorcin[4]arene cavitands by ring-closing metathesis.

Parulekar SN, Muppalla K, Fronczek FR, Bisht KS.

Chem Commun (Camb). 2007 Dec 14;(46):4901-3.

PMID:
18361363
22.

DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells.

Mishra MV, Bisht KS, Sun L, Muldoon-Jacobs K, Awwad R, Kaushal A, Nguyen P, Huang L, Pennington JD, Markovina S, Bradbury CM, Gius D.

Mol Cancer Res. 2008 Feb;6(2):243-9. doi: 10.1158/1541-7786.MCR-07-0373.

23.

The epigenome as a molecular marker and target.

Gius D, Bradbury CM, Sun L, Awwad RT, Huang L, Smart DD, Bisht KS, Ho AS, Nguyen P.

Cancer. 2005 Nov 1;104(9):1789-93. Review.

24.

Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach.

Gius D, Cui H, Bradbury CM, Cook J, Smart DK, Zhao S, Young L, Brandenburg SA, Hu Y, Bisht KS, Ho AS, Mattson D, Sun L, Munson PJ, Chuang EY, Mitchell JB, Feinberg AP.

Cancer Cell. 2004 Oct;6(4):361-71.

25.

Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress.

Smart DK, Ortiz KL, Mattson D, Bradbury CM, Bisht KS, Sieck LK, Brechbiel MW, Gius D.

Cancer Res. 2004 Sep 15;64(18):6716-24.

26.
27.

Heat shock and the activation of AP-1 and inhibition of NF-kappa B DNA-binding activity: possible role of intracellular redox status.

Mattson D, Bradbury CM, Bisht KS, Curry HA, Spitz DR, Gius D.

Int J Hyperthermia. 2004 Mar;20(2):224-33.

PMID:
15195516
28.
29.

Intramolecular inclusion in novel octaester cavitands.

Dueno EE, Bisht KS.

Chem Commun (Camb). 2004 Apr 21;(8):954-5. Epub 2004 Mar 11.

PMID:
15069491
30.

Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells.

Bisht KS, Bradbury CM, Zoberi I, Curry HA, Kaushal A, Roti Roti JL, Gius D.

Int J Radiat Biol. 2003 Nov;79(11):879-88.

PMID:
14698956
31.

Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.

Bisht KS, Bradbury CM, Mattson D, Kaushal A, Sowers A, Markovina S, Ortiz KL, Sieck LK, Isaacs JS, Brechbiel MW, Mitchell JB, Neckers LM, Gius D.

Cancer Res. 2003 Dec 15;63(24):8984-95.

32.

The effect of 835.62 MHz FDMA or 847.74 MHz CDMA modulated radiofrequency radiation on the induction of micronuclei in C3H 10T(1/2) cells.

Bisht KS, Moros EG, Straube WL, Baty JD, Roti Roti JL.

Radiat Res. 2002 May;157(5):506-15.

PMID:
11966316
33.

Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines.

Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, Gius D.

Cancer Lett. 2002 Jan 25;175(2):165-73.

PMID:
11741744
35.

Micronuclei in the peripheral blood and bone marrow cells of rats exposed to 2450 MHz radiofrequency radiation.

Vijayalaxmi, Pickard WF, Bisht KS, Prihoda TJ, Meltz ML, LaRegina MC, Roti Roti JL, Straube WL, Moros EG.

Int J Radiat Biol. 2001 Nov;77(11):1109-15.

PMID:
11683981
36.

Enzyme-Mediated Regioselective Acylations of Sophorolipids.

Bisht KS, Gross RA, Kaplan DL.

J Org Chem. 1999 Feb 5;64(3):780-789.

PMID:
11674146
37.
38.

Measurement of DNA damage in mammalian cells exposed in vitro to radiofrequency fields at SARs of 3-5 W/kg.

Li L, Bisht KS, LaGroye I, Zhang P, Straube WL, Moros EG, Roti Roti JL.

Radiat Res. 2001 Sep;156(3):328-32.

PMID:
11500143
39.

Modification of radiation induced damage in mouse intestine by WR-2721.

Bisht KS, Prabhu S, Devi PU.

Indian J Exp Biol. 2000 Jul;38(7):669-74.

PMID:
11215309
40.

Neoplastic transformation in C3H 10T(1/2) cells after exposure to 835.62 MHz FDMA and 847.74 MHz CDMA radiations.

Roti Roti JL, Malyapa RS, Bisht KS, Ahern EW, Moros EG, Pickard WF, Straube WL.

Radiat Res. 2001 Jan;155(1 Pt 2):239-247.

PMID:
11121241
41.

Cytogenetic studies in human blood lymphocytes exposed in vitro to radiofrequency radiation at a cellular telephone frequency (835.62 MHz, FDMA).

Vijayalaxmi, Leal BZ, Meltz ML, Pickard WF, Bisht KS, Roti Roti JL, Straube WL, Moros EG.

Radiat Res. 2001 Jan;155(1 Pt 1):113-21.

PMID:
11121222
42.

Constituents of the yew trees.

Parmar VS, Jha A, Bisht KS, Taneja P, Singh SK, Kumar A, Poonam, Jain R, Olsen CE.

Phytochemistry. 1999 Apr;50(8):1267-304. Review.

PMID:
10326254
43.
44.

Effect of late fetal irradiation on adult behavior of mouse: Dose-response relationship.

Devi PU, Hossain M, Bisht KS.

Neurotoxicol Teratol. 1999 Mar-Apr;21(2):193-8.

PMID:
10192280
45.

Effect of gamma radiation on the foetal haemopoietic system in the mouse.

Uma Devi P, Hossain M, Bisht KS.

Int J Radiat Biol. 1998 Nov;74(5):639-46.

PMID:
9848283
46.
47.

Lipase-catalysed selective deacetylation of phenolic/enolic acetoxy groups in peracetylated benzyl phenyl ketones.

Parmar VS, Pati HN, Azim A, Kumar R, Himanshu, Bisht KS, Prasad AK, Errington W.

Bioorg Med Chem. 1998 Jan;6(1):109-18.

PMID:
9502110
48.

Anti-invasive activity of alkaloids and polyphenolics in vitro.

Parmar VS, Bracke ME, Philippe J, Wengel J, Jain SC, Olsen CE, Bisht KS, Sharma NK, Courtens A, Sharma SK, Vennekens K, Van Marck V, Singh SK, Kumar N, Kumar A, Malhotra S, Kumar R, Rajwanshi VK, Jain R, Mareel MM.

Bioorg Med Chem. 1997 Aug;5(8):1609-19.

PMID:
9313866
49.

Hyperthermia in cancer research: current status.

Bisht KS, Uma Devi P.

Indian J Exp Biol. 1996 Dec;34(12):1183-9. Review.

PMID:
9246907
50.

Chemoprevention of carcinogen-DNA binding: the relative role of different oxygenated substituents on 4-methylcoumarins in the inhibition of aflatoxin B1-DNA binding in vitro.

Raj HG, Gupta S, Biswas G, Singh S, Singh A, Jha A, Bisht KS, Sharma SK, Jain SC, Parmar VS.

Bioorg Med Chem. 1996 Dec;4(12):2225-8.

PMID:
9022986

Supplemental Content

Loading ...
Support Center